REG - Alliance Pharma PLC - Major Interest in Shares <ALAPH.L>
.
For best results when printing this announcement, please click on the link below:
http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20100622:nRSV0125Oa
RNS Number : 0125O
Alliance Pharma PLC
22 June 2010
For immediate release 22 June 2010
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Major interest in shares
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was today informed that Nigel Wray purchased, on
21
June 2010, 800,000 ordinary shares of 1p each in the Company.
Mr Wray's resultant shareholding is 26,069,995 ordinary shares, equivalent to 11.26% of the Company's issued share
capital.
Mr Wray's ordinary shares are held as follows:
Nominee Number of ordinary shares
Pershing Nominees LimitedSmith & Williamson Nominees LimitedRoy Nominees Limited 9,405,40750,00016,614,588
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive Officer
Richard Wright, Finance Director
www.alliancepharma.co.uk
Buchanan Communications + 44 (0) 20 7466 5000
Mark Court / Stasa Filiplic
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Brent Nabbs
Corporate Broking: David Poutney
Corporate Broking: David Poutney
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights
to
more than 50 pharmaceutical products and continues to explore opportunities to expand the range.
Alliance's products are prescribed in the treatment of a wide range of conditions and include products used in the
treatment of dermatological conditions, in oncology, in childbirth, in the prevention of heart disease, in Parkinson's
disease, in nutrition and in nasal infections. Alliance's sales are mainly prescription driven. Its products are
distributed both to hospitals directly and to pharmaceutical wholesalers, which in turn service both hospital and retail
pharmacies with their prescription requirements.
Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
